Comparison of postoperative analgesia with epidural butorphanol/bupivacaine versus fentanyl/bupivacaine following pediatric urological procedures

Alexandra Szabova, MD; Senthilkumar Sadhasivam, MD, MPH; Yu Wang, MS; Todd G. Nick, PhD; Kenneth Goldschneider, MD

doi:10.5055/jom.2010.0037

Authors

Alexandra Szabova, MD
Senthilkumar Sadhasivam, MD, MPH
Yu Wang, MS
Todd G. Nick, PhD
Kenneth Goldschneider, MD

DOI:

https://doi.org/10.5055/jom.2010.0037

Keywords:

epidural, butorphanol, pediatric

Abstract

Background: The aim of this retrospective study is to compare safety and efficacy of postoperative epidural butorphanol/bupivacaine with the gold-standard epidural analgesic infusion fentanyl/bupivacaine in children.
Methods: With the Institutional Review Board’s approval, the authors searched their Pain Management Database and divided children who received epidural analgesia into two groups. Each butorphanol group subject was matched with two fentanyl group subjects. Demographic data, pain scores, epidural interventions, epidural side effects, use of rescue opioid analgesia and adjuvant analgesics, causes of epidural failure, time of first oral intake and ambulation, and length of stay were statistically compared.
Results: A total of 191 patients were identified between 2000 and 2007; 58 in epidural butorphanol/bupivacaine and 133 in fentanyl/bupivacaine groups. Demographic data were comparable between the groups. The number of children with good pain control on postoperative days 1 and 2 in butorphanol (84 and 82 percent) and fentanyl (93 and 91 percent) groups were statistically similar (p = 0.06 and 0.13, respectively). Incidences of epidural side effects, especially pruritus, were significantly higher in the fentanyl group. Significantly more children in the butorphanol group required epidural rate changes when compared with those in the fentanyl group. Incidence of failed epidurals was significantly higher in the fentanyl group when compared with that in the butorphanol group. Clinically significant respiratory depression occurred in two children in the fentanyl group and in none of the children in the butorphanol group (p > 0.99).
Conclusions: Epidural butorphanol provided similar analgesia to epidural fentanyl after urological procedures in children, but butorphanol caused less pruritus than fentanyl.
Implication statement: Epidural analgesia with butorphanol/bupivacaine is effective in children undergoing urological procedures. When compared with epidural fentanyl, epidural butorphanol causes significantly less itching.

Author Biographies

Alexandra Szabova, MD

Department of Anesthesia, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio.

Senthilkumar Sadhasivam, MD, MPH

Department of Anesthesia, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio.

Yu Wang, MS

Division of Biostatistics and Epidemiology, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio.

Todd G. Nick, PhD

Department of Pediatrics and Biostatistics, University of Arkansas for Medical Sciences, College of Medicine, Little Rock, Arkansas.

Kenneth Goldschneider, MD

Department of Anesthesia, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio.

References

Bailey AG, Valley RD, Freid EB, et al.: Epidural morphine combined with epidural or intravenous butorphanol for postoperative analgesia in pediatric patients. Anesth Analg. 1994; 79: 340-344.

Lawhorn CD, Boop F, Brown R, et al.: Epidural pain management in the postrhizotomy patient. Pediatr Neurosurg. 1994; 20: 198-202.

Lawhorn CD, Brown RE Jr: Epidural morphine with butorphanol in pediatric patients. J Clin Anesth. 1994; 6: 91-94.

Lawhorn CD, Boop FA, Brown RE Jr, et al.: Continuous epidural morphine/butorphanol infusion following selective dorsal rhizotomy in children. Childs Nerv Syst. 1995; 11: 621-624.

Lawhorn CD, Stoner JM, Schmitz ML, et al.: Caudal epidural butorphanol plus bupivacaine versus bupivacaine in pediatric out-patient genitourinary procedures. J Clin Anesth. 1997; 9: 103-108.

Lippmann M, Mok MS: Epidural butorphanol for the relief of postoperative pain. Anesth Analg. 1988; 67: 418.

Gunter JB, McAuliffe J, Gregg T, et al.: Continuous epidural butorphanol relieves pruritus associated with epidural morphine infusions in children. Paediatr Anaesth. 2000; 10: 167-172.

Wewers ME, Lowe NK: A critical review of visual analogue scales in the measurement of clinical phenomena. Res Nurs Health. 1990; 13: 227-236.

Lawrence J, Alcock D, McGrath P, et al.: The development of a tool to assess neonatal pain. Neonatal Netw. 1993; 12: 59-66.

McGrath P, Johnson G, Goodman J, et al.: CHEOPS: A behavioral scale for rating postoperative pain in children. In Fields HL, Dubner R, Cerveros R (eds.): Advances in Pain and Research Therapy. New York: Raven Press, 1985: 395-402.

Beyer JE, Denyes MJ, Villarruel AM: The creation, validation, and continuing development of the Oucher: A measure of pain intensity in children. J Pediatr Nurs. 1992; 7: 335-346.

Lee H, Naughton NN, Woods JH, et al.: Effects of butorphanol on morphine-induced itch and analgesia in primates. Anesthesiology. 2007; 107: 478-485.

Abboud TK, Afrasiabi A, Zhu J, et al.: Epidural morphine or butorphanol augments bupivacaine analgesia during labor. Reg Anesth. 1989; 14: 115-120.

Merkel SI, Lewis-Voepel T, Shayevitz JR, et al.: The FLACC: A behavioral scale for scoring postoperative pain in young children. Pediatr Nurs. 1997; 23: 293-297.

Power I, Brown DT, Wildsmith JA: The effect of fentanyl, meperidine and diamorphine on nerve conduction in vitro. Reg Anesth. 1991; 16: 204-208.

Rawal N, Nuutinen L, Raj PP, et al.: Behavioral and histopathologic effects following intrathecal administration of butorphanol, sufentanil, and nalbuphine in sheep. Anesthesiology. 1991; 75: 1025-1034.

McGrath PJ, Walco GA, Turk DC, et al.: Core outcome domains and measures for pediatric acute and chronic/recurrent pain clinical trials: PedIMMPACT recommendations. J Pain. 2008; 9(9): 771-783.